Hyperprogressive disease during treatment with immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC).
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Pablo Ayala de Miguel, Javier López Gallego, Itziar Gorospe García, Pablo René Rivera Vargas, Andrea Posada Restrepo, Jonathan Aires Machado, Rubén Alonso Calderón, José Manuel Rodríguez García, Eduardo Ceballos, Alfonso Acero Caballero, Andrea Illán Varella, Laura Quintana Cortés, Pablo Borrega Garcia
Institutions: Hospital San Pedro de Alcántara, Hospital Virgen del Puerto
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3028947754